nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—ACHE—Irinotecan—lung cancer	0.324	1	CbGbCtD
Gallamine Triethiodide—Diarrhoea—Vinblastine—lung cancer	0.000509	0.00114	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Etoposide—lung cancer	0.000509	0.00114	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Cisplatin—lung cancer	0.000508	0.00114	CcSEcCtD
Gallamine Triethiodide—Pruritus—Erlotinib—lung cancer	0.000506	0.00114	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Irinotecan—lung cancer	0.000499	0.00112	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Paclitaxel—lung cancer	0.000499	0.00112	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Docetaxel—lung cancer	0.000498	0.00112	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Docetaxel—lung cancer	0.000497	0.00112	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Docetaxel—lung cancer	0.000496	0.00112	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Topotecan—lung cancer	0.000494	0.00111	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Docetaxel—lung cancer	0.000493	0.00111	CcSEcCtD
Gallamine Triethiodide—Urticaria—Vinorelbine—lung cancer	0.000491	0.0011	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Erlotinib—lung cancer	0.000489	0.0011	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Vinorelbine—lung cancer	0.000489	0.0011	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Vinorelbine—lung cancer	0.000489	0.0011	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Gemcitabine—lung cancer	0.000486	0.00109	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Gemcitabine—lung cancer	0.000482	0.00108	CcSEcCtD
Gallamine Triethiodide—Anaemia—Etoposide—lung cancer	0.00048	0.00108	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000479	0.00108	CcSEcCtD
Gallamine Triethiodide—Vomiting—Vinblastine—lung cancer	0.000473	0.00106	CcSEcCtD
Gallamine Triethiodide—Anaemia—Paclitaxel—lung cancer	0.000471	0.00106	CcSEcCtD
Gallamine Triethiodide—Malaise—Etoposide—lung cancer	0.000468	0.00105	CcSEcCtD
Gallamine Triethiodide—Headache—Vinblastine—lung cancer	0.000466	0.00105	CcSEcCtD
Gallamine Triethiodide—Angioedema—Paclitaxel—lung cancer	0.000465	0.00105	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Etoposide—lung cancer	0.000465	0.00105	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Docetaxel—lung cancer	0.000463	0.00104	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Docetaxel—lung cancer	0.00046	0.00104	CcSEcCtD
Gallamine Triethiodide—Vomiting—Topotecan—lung cancer	0.000459	0.00103	CcSEcCtD
Gallamine Triethiodide—Malaise—Paclitaxel—lung cancer	0.000459	0.00103	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Irinotecan—lung cancer	0.000458	0.00103	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Paclitaxel—lung cancer	0.000456	0.00103	CcSEcCtD
Gallamine Triethiodide—Rash—Topotecan—lung cancer	0.000456	0.00102	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Vinorelbine—lung cancer	0.000455	0.00102	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Topotecan—lung cancer	0.000455	0.00102	CcSEcCtD
Gallamine Triethiodide—Vomiting—Erlotinib—lung cancer	0.000454	0.00102	CcSEcCtD
Gallamine Triethiodide—Cough—Etoposide—lung cancer	0.000453	0.00102	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Cisplatin—lung cancer	0.000453	0.00102	CcSEcCtD
Gallamine Triethiodide—Headache—Topotecan—lung cancer	0.000453	0.00102	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000452	0.00102	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Cisplatin—lung cancer	0.000452	0.00102	CcSEcCtD
Gallamine Triethiodide—Rash—Erlotinib—lung cancer	0.000451	0.00101	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Erlotinib—lung cancer	0.00045	0.00101	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Cisplatin—lung cancer	0.00045	0.00101	CcSEcCtD
Gallamine Triethiodide—Headache—Erlotinib—lung cancer	0.000448	0.00101	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Doxorubicin—lung cancer	0.000447	0.00101	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Gemcitabine—lung cancer	0.000446	0.001	CcSEcCtD
Gallamine Triethiodide—Cough—Paclitaxel—lung cancer	0.000444	0.001	CcSEcCtD
Gallamine Triethiodide—Asthenia—Vinorelbine—lung cancer	0.000443	0.000998	CcSEcCtD
Gallamine Triethiodide—Chest pain—Etoposide—lung cancer	0.000442	0.000995	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Methotrexate—lung cancer	0.000442	0.000995	CcSEcCtD
Gallamine Triethiodide—Nausea—Vinblastine—lung cancer	0.000442	0.000994	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Irinotecan—lung cancer	0.00044	0.00099	CcSEcCtD
Gallamine Triethiodide—Fatigue—Irinotecan—lung cancer	0.000439	0.000989	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000439	0.000988	CcSEcCtD
Gallamine Triethiodide—Pruritus—Vinorelbine—lung cancer	0.000437	0.000984	CcSEcCtD
Gallamine Triethiodide—Pain—Irinotecan—lung cancer	0.000436	0.000981	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Paclitaxel—lung cancer	0.000434	0.000976	CcSEcCtD
Gallamine Triethiodide—Chest pain—Paclitaxel—lung cancer	0.000434	0.000976	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000431	0.000969	CcSEcCtD
Gallamine Triethiodide—Nausea—Topotecan—lung cancer	0.000429	0.000965	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000429	0.000964	CcSEcCtD
Gallamine Triethiodide—Abdominal discomfort—Methotrexate—lung cancer	0.000428	0.000963	CcSEcCtD
Gallamine Triethiodide—Fatigue—Gemcitabine—lung cancer	0.000428	0.000963	CcSEcCtD
Gallamine Triethiodide—Confusional state—Etoposide—lung cancer	0.000428	0.000962	CcSEcCtD
Gallamine Triethiodide—Pain—Gemcitabine—lung cancer	0.000425	0.000955	CcSEcCtD
Gallamine Triethiodide—Nausea—Erlotinib—lung cancer	0.000425	0.000955	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Methotrexate—lung cancer	0.000424	0.000954	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Vinorelbine—lung cancer	0.000423	0.000951	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Docetaxel—lung cancer	0.000423	0.000951	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000422	0.000949	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Irinotecan—lung cancer	0.00042	0.000945	CcSEcCtD
Gallamine Triethiodide—Confusional state—Paclitaxel—lung cancer	0.000419	0.000943	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Cisplatin—lung cancer	0.000416	0.000935	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Etoposide—lung cancer	0.000415	0.000934	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Etoposide—lung cancer	0.000414	0.000931	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Etoposide—lung cancer	0.000412	0.000926	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Gemcitabine—lung cancer	0.000409	0.00092	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Doxorubicin—lung cancer	0.000409	0.000919	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Paclitaxel—lung cancer	0.000407	0.000916	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Paclitaxel—lung cancer	0.000406	0.000913	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Paclitaxel—lung cancer	0.000404	0.000908	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Irinotecan—lung cancer	0.000403	0.000907	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Irinotecan—lung cancer	0.000403	0.000907	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Doxorubicin—lung cancer	0.0004	0.0009	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Cisplatin—lung cancer	0.0004	0.000899	CcSEcCtD
Gallamine Triethiodide—Anaemia—Docetaxel—lung cancer	0.000399	0.000898	CcSEcCtD
Gallamine Triethiodide—Pain—Cisplatin—lung cancer	0.000396	0.00089	CcSEcCtD
Gallamine Triethiodide—Vomiting—Vinorelbine—lung cancer	0.000393	0.000884	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Gemcitabine—lung cancer	0.000393	0.000883	CcSEcCtD
Gallamine Triethiodide—Rash—Vinorelbine—lung cancer	0.00039	0.000877	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Vinorelbine—lung cancer	0.000389	0.000876	CcSEcCtD
Gallamine Triethiodide—Headache—Vinorelbine—lung cancer	0.000387	0.000871	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Docetaxel—lung cancer	0.000386	0.000869	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Doxorubicin—lung cancer	0.000383	0.000861	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Cisplatin—lung cancer	0.000381	0.000858	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Etoposide—lung cancer	0.000381	0.000856	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000379	0.000852	CcSEcCtD
Gallamine Triethiodide—Cough—Docetaxel—lung cancer	0.000377	0.000848	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Irinotecan—lung cancer	0.000376	0.000845	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Paclitaxel—lung cancer	0.000373	0.00084	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Docetaxel—lung cancer	0.000368	0.000827	CcSEcCtD
Gallamine Triethiodide—Chest pain—Docetaxel—lung cancer	0.000368	0.000827	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Doxorubicin—lung cancer	0.000367	0.000826	CcSEcCtD
Gallamine Triethiodide—Nausea—Vinorelbine—lung cancer	0.000367	0.000826	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Etoposide—lung cancer	0.000366	0.000823	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Cisplatin—lung cancer	0.000366	0.000823	CcSEcCtD
Gallamine Triethiodide—Asthenia—Irinotecan—lung cancer	0.000366	0.000823	CcSEcCtD
Gallamine Triethiodide—Fatigue—Etoposide—lung cancer	0.000366	0.000822	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000365	0.000821	CcSEcCtD
Gallamine Triethiodide—Pain—Etoposide—lung cancer	0.000363	0.000816	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Methotrexate—lung cancer	0.000359	0.000808	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000359	0.000807	CcSEcCtD
Gallamine Triethiodide—Fatigue—Paclitaxel—lung cancer	0.000358	0.000806	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Methotrexate—lung cancer	0.000357	0.000804	CcSEcCtD
Gallamine Triethiodide—Asthenia—Gemcitabine—lung cancer	0.000356	0.000801	CcSEcCtD
Gallamine Triethiodide—Pain—Paclitaxel—lung cancer	0.000355	0.0008	CcSEcCtD
Gallamine Triethiodide—Confusional state—Docetaxel—lung cancer	0.000355	0.000799	CcSEcCtD
Gallamine Triethiodide—Pruritus—Gemcitabine—lung cancer	0.000351	0.00079	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Etoposide—lung cancer	0.000349	0.000786	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Irinotecan—lung cancer	0.000349	0.000785	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Docetaxel—lung cancer	0.000345	0.000776	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Docetaxel—lung cancer	0.000344	0.000774	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Paclitaxel—lung cancer	0.000343	0.000771	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Docetaxel—lung cancer	0.000342	0.00077	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Cisplatin—lung cancer	0.000341	0.000767	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Gemcitabine—lung cancer	0.00034	0.000764	CcSEcCtD
Gallamine Triethiodide—Urticaria—Etoposide—lung cancer	0.000337	0.000758	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Etoposide—lung cancer	0.000335	0.000754	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Etoposide—lung cancer	0.000335	0.000754	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Methotrexate—lung cancer	0.000334	0.000752	CcSEcCtD
Gallamine Triethiodide—Asthenia—Cisplatin—lung cancer	0.000332	0.000747	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Methotrexate—lung cancer	0.000332	0.000746	CcSEcCtD
Gallamine Triethiodide—Urticaria—Paclitaxel—lung cancer	0.00033	0.000743	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Paclitaxel—lung cancer	0.000329	0.000739	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Paclitaxel—lung cancer	0.000329	0.000739	CcSEcCtD
Gallamine Triethiodide—Vomiting—Irinotecan—lung cancer	0.000324	0.000729	CcSEcCtD
Gallamine Triethiodide—Rash—Irinotecan—lung cancer	0.000321	0.000723	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Irinotecan—lung cancer	0.000321	0.000722	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000321	0.000722	CcSEcCtD
Gallamine Triethiodide—Headache—Irinotecan—lung cancer	0.000319	0.000718	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Cisplatin—lung cancer	0.000317	0.000712	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Docetaxel—lung cancer	0.000316	0.000712	CcSEcCtD
Gallamine Triethiodide—Vomiting—Gemcitabine—lung cancer	0.000316	0.00071	CcSEcCtD
Gallamine Triethiodide—Rash—Gemcitabine—lung cancer	0.000313	0.000704	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Gemcitabine—lung cancer	0.000313	0.000704	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Etoposide—lung cancer	0.000312	0.000703	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Doxorubicin—lung cancer	0.000311	0.0007	CcSEcCtD
Gallamine Triethiodide—Headache—Gemcitabine—lung cancer	0.000311	0.0007	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Doxorubicin—lung cancer	0.00031	0.000698	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Doxorubicin—lung cancer	0.00031	0.000696	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Doxorubicin—lung cancer	0.000308	0.000693	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Paclitaxel—lung cancer	0.000306	0.000689	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Methotrexate—lung cancer	0.000305	0.000686	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Docetaxel—lung cancer	0.000304	0.000684	CcSEcCtD
Gallamine Triethiodide—Asthenia—Etoposide—lung cancer	0.000304	0.000684	CcSEcCtD
Gallamine Triethiodide—Fatigue—Docetaxel—lung cancer	0.000304	0.000683	CcSEcCtD
Gallamine Triethiodide—Nausea—Irinotecan—lung cancer	0.000303	0.000681	CcSEcCtD
Gallamine Triethiodide—Pain—Docetaxel—lung cancer	0.000301	0.000678	CcSEcCtD
Gallamine Triethiodide—Pruritus—Etoposide—lung cancer	0.0003	0.000675	CcSEcCtD
Gallamine Triethiodide—Asthenia—Paclitaxel—lung cancer	0.000298	0.000671	CcSEcCtD
Gallamine Triethiodide—Nausea—Gemcitabine—lung cancer	0.000295	0.000663	CcSEcCtD
Gallamine Triethiodide—Vomiting—Cisplatin—lung cancer	0.000294	0.000662	CcSEcCtD
Gallamine Triethiodide—Pruritus—Paclitaxel—lung cancer	0.000294	0.000662	CcSEcCtD
Gallamine Triethiodide—Rash—Cisplatin—lung cancer	0.000292	0.000656	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Cisplatin—lung cancer	0.000292	0.000656	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Docetaxel—lung cancer	0.00029	0.000653	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Etoposide—lung cancer	0.00029	0.000653	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Doxorubicin—lung cancer	0.000289	0.000651	CcSEcCtD
Gallamine Triethiodide—Anaemia—Methotrexate—lung cancer	0.000288	0.000647	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Doxorubicin—lung cancer	0.000287	0.000646	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Paclitaxel—lung cancer	0.000284	0.00064	CcSEcCtD
Gallamine Triethiodide—Malaise—Methotrexate—lung cancer	0.000281	0.000631	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Docetaxel—lung cancer	0.000279	0.000627	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Docetaxel—lung cancer	0.000279	0.000627	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Methotrexate—lung cancer	0.000279	0.000627	CcSEcCtD
Gallamine Triethiodide—Nausea—Cisplatin—lung cancer	0.000275	0.000618	CcSEcCtD
Gallamine Triethiodide—Cough—Methotrexate—lung cancer	0.000272	0.000611	CcSEcCtD
Gallamine Triethiodide—Vomiting—Etoposide—lung cancer	0.00027	0.000606	CcSEcCtD
Gallamine Triethiodide—Rash—Etoposide—lung cancer	0.000267	0.000601	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Etoposide—lung cancer	0.000267	0.000601	CcSEcCtD
Gallamine Triethiodide—Headache—Etoposide—lung cancer	0.000266	0.000598	CcSEcCtD
Gallamine Triethiodide—Chest pain—Methotrexate—lung cancer	0.000265	0.000596	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Methotrexate—lung cancer	0.000265	0.000596	CcSEcCtD
Gallamine Triethiodide—Vomiting—Paclitaxel—lung cancer	0.000264	0.000595	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Doxorubicin—lung cancer	0.000264	0.000594	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000263	0.000592	CcSEcCtD
Gallamine Triethiodide—Rash—Paclitaxel—lung cancer	0.000262	0.00059	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Paclitaxel—lung cancer	0.000262	0.000589	CcSEcCtD
Gallamine Triethiodide—Headache—Paclitaxel—lung cancer	0.00026	0.000586	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Docetaxel—lung cancer	0.00026	0.000584	CcSEcCtD
Gallamine Triethiodide—Confusional state—Methotrexate—lung cancer	0.000256	0.000576	CcSEcCtD
Gallamine Triethiodide—Asthenia—Docetaxel—lung cancer	0.000253	0.000569	CcSEcCtD
Gallamine Triethiodide—Nausea—Etoposide—lung cancer	0.000252	0.000567	CcSEcCtD
Gallamine Triethiodide—Pruritus—Docetaxel—lung cancer	0.000249	0.000561	CcSEcCtD
Gallamine Triethiodide—Anaemia—Doxorubicin—lung cancer	0.000249	0.00056	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Methotrexate—lung cancer	0.000249	0.000559	CcSEcCtD
Gallamine Triethiodide—Nausea—Paclitaxel—lung cancer	0.000247	0.000556	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Methotrexate—lung cancer	0.000247	0.000555	CcSEcCtD
Gallamine Triethiodide—Malaise—Doxorubicin—lung cancer	0.000243	0.000547	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Doxorubicin—lung cancer	0.000241	0.000543	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Docetaxel—lung cancer	0.000241	0.000542	CcSEcCtD
Gallamine Triethiodide—Cough—Doxorubicin—lung cancer	0.000235	0.000529	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000231	0.000521	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Doxorubicin—lung cancer	0.000229	0.000516	CcSEcCtD
Gallamine Triethiodide—Chest pain—Doxorubicin—lung cancer	0.000229	0.000516	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Methotrexate—lung cancer	0.000228	0.000513	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000228	0.000513	CcSEcCtD
Gallamine Triethiodide—Vomiting—Docetaxel—lung cancer	0.000224	0.000504	CcSEcCtD
Gallamine Triethiodide—Rash—Docetaxel—lung cancer	0.000222	0.0005	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Docetaxel—lung cancer	0.000222	0.000499	CcSEcCtD
Gallamine Triethiodide—Confusional state—Doxorubicin—lung cancer	0.000222	0.000499	CcSEcCtD
Gallamine Triethiodide—Headache—Docetaxel—lung cancer	0.000221	0.000497	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Methotrexate—lung cancer	0.000219	0.000493	CcSEcCtD
Gallamine Triethiodide—Fatigue—Methotrexate—lung cancer	0.000219	0.000493	CcSEcCtD
Gallamine Triethiodide—Pain—Methotrexate—lung cancer	0.000217	0.000489	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Doxorubicin—lung cancer	0.000215	0.000484	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Doxorubicin—lung cancer	0.000215	0.000483	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Doxorubicin—lung cancer	0.000214	0.000481	CcSEcCtD
Gallamine Triethiodide—Nausea—Docetaxel—lung cancer	0.000209	0.000471	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Methotrexate—lung cancer	0.000209	0.000471	CcSEcCtD
Gallamine Triethiodide—Urticaria—Methotrexate—lung cancer	0.000202	0.000454	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Methotrexate—lung cancer	0.000201	0.000452	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Methotrexate—lung cancer	0.000201	0.000452	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.0002	0.000451	CcSEcCtD
Gallamine Triethiodide—ACHE—Metabolism—HSD17B10—lung cancer	0.0002	0.000861	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—APP—lung cancer	0.000199	0.000858	CbGpPWpGaD
Gallamine Triethiodide—Paraesthesia—Doxorubicin—lung cancer	0.000197	0.000444	CcSEcCtD
Gallamine Triethiodide—ACHE—Metabolism of proteins—ATF3—lung cancer	0.000196	0.000845	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—APC—lung cancer	0.000195	0.000843	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CG—lung cancer	0.000195	0.000843	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—EGF—lung cancer	0.000193	0.000834	CbGpPWpGaD
Gallamine Triethiodide—Gastrointestinal disorder—Doxorubicin—lung cancer	0.00019	0.000427	CcSEcCtD
Gallamine Triethiodide—Fatigue—Doxorubicin—lung cancer	0.00019	0.000427	CcSEcCtD
Gallamine Triethiodide—Pain—Doxorubicin—lung cancer	0.000188	0.000423	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Methotrexate—lung cancer	0.000187	0.000421	CcSEcCtD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	0.000186	0.000801	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CKB—lung cancer	0.000186	0.000801	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	0.000185	0.000799	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—BRAF—lung cancer	0.000184	0.000793	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	0.000183	0.00079	CbGpPWpGaD
Gallamine Triethiodide—Asthenia—Methotrexate—lung cancer	0.000182	0.00041	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Doxorubicin—lung cancer	0.000181	0.000408	CcSEcCtD
Gallamine Triethiodide—Pruritus—Methotrexate—lung cancer	0.00018	0.000404	CcSEcCtD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	0.000179	0.000773	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—MDM2—lung cancer	0.000179	0.000772	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—RAF1—lung cancer	0.000178	0.00077	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—LMNA—lung cancer	0.000176	0.000759	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GIPR—lung cancer	0.000175	0.000756	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000175	0.000755	CbGpPWpGaD
Gallamine Triethiodide—Urticaria—Doxorubicin—lung cancer	0.000175	0.000393	CcSEcCtD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000175	0.000754	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTM2—lung cancer	0.000174	0.000753	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CNDP2—lung cancer	0.000174	0.000753	CbGpPWpGaD
Gallamine Triethiodide—Body temperature increased—Doxorubicin—lung cancer	0.000174	0.000391	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Doxorubicin—lung cancer	0.000174	0.000391	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Methotrexate—lung cancer	0.000174	0.000391	CcSEcCtD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—MAP2K1—lung cancer	0.000173	0.000746	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CD—lung cancer	0.000172	0.000741	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—PTHLH—lung cancer	0.00017	0.000733	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—MTMR3—lung cancer	0.00017	0.000732	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	0.000166	0.000717	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PGAM1—lung cancer	0.000165	0.000714	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—BRAF—lung cancer	0.000164	0.000706	CbGpPWpGaD
Gallamine Triethiodide—Hypersensitivity—Doxorubicin—lung cancer	0.000162	0.000364	CcSEcCtD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	0.000162	0.000698	CbGpPWpGaD
Gallamine Triethiodide—Vomiting—Methotrexate—lung cancer	0.000161	0.000363	CcSEcCtD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	0.000161	0.000697	CbGpPWpGaD
Gallamine Triethiodide—Rash—Methotrexate—lung cancer	0.00016	0.00036	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Methotrexate—lung cancer	0.00016	0.00036	CcSEcCtD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—ANXA1—lung cancer	0.00016	0.000689	CbGpPWpGaD
Gallamine Triethiodide—Headache—Methotrexate—lung cancer	0.000159	0.000358	CcSEcCtD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GIPR—lung cancer	0.000159	0.000686	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—HRAS—lung cancer	0.000159	0.000685	CbGpPWpGaD
Gallamine Triethiodide—Asthenia—Doxorubicin—lung cancer	0.000158	0.000355	CcSEcCtD
Gallamine Triethiodide—ACHE—Metabolism—CYP2A7—lung cancer	0.000158	0.000681	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	0.000156	0.000675	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	0.000156	0.000674	CbGpPWpGaD
Gallamine Triethiodide—Pruritus—Doxorubicin—lung cancer	0.000156	0.00035	CcSEcCtD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AVP—lung cancer	0.000155	0.000667	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SDC4—lung cancer	0.000154	0.000666	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—RAF1—lung cancer	0.000153	0.000662	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—APP—lung cancer	0.000151	0.000653	CbGpPWpGaD
Gallamine Triethiodide—Nausea—Methotrexate—lung cancer	0.000151	0.000339	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Doxorubicin—lung cancer	0.00015	0.000338	CcSEcCtD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CB—lung cancer	0.00015	0.000646	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GRM8—lung cancer	0.000149	0.000643	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	0.000149	0.000643	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	0.000145	0.000625	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Phospholipid metabolism—PIK3CA—lung cancer	0.000143	0.000617	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	0.000141	0.000609	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—RRM1—lung cancer	0.000141	0.000607	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTA3—lung cancer	0.000141	0.000607	CbGpPWpGaD
Gallamine Triethiodide—Vomiting—Doxorubicin—lung cancer	0.00014	0.000315	CcSEcCtD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000139	0.000599	CbGpPWpGaD
Gallamine Triethiodide—Rash—Doxorubicin—lung cancer	0.000139	0.000312	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Doxorubicin—lung cancer	0.000139	0.000312	CcSEcCtD
Gallamine Triethiodide—Headache—Doxorubicin—lung cancer	0.000138	0.00031	CcSEcCtD
Gallamine Triethiodide—ACHE—Neuronal System—MDM2—lung cancer	0.000137	0.000592	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—RAF1—lung cancer	0.000137	0.00059	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GRM8—lung cancer	0.000135	0.000584	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	0.000133	0.000576	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000133	0.000573	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—B4GALT5—lung cancer	0.000132	0.000571	CbGpPWpGaD
Gallamine Triethiodide—Nausea—Doxorubicin—lung cancer	0.000131	0.000294	CcSEcCtD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	0.00013	0.00056	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—POMC—lung cancer	0.000129	0.000558	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—JUN—lung cancer	0.000129	0.000556	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTA4—lung cancer	0.000129	0.000555	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	0.000127	0.000548	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	0.000126	0.000543	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTA2—lung cancer	0.000125	0.000541	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AXL—lung cancer	0.000124	0.000535	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—OXTR—lung cancer	0.000123	0.000529	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GRP—lung cancer	0.000123	0.000529	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—HRAS—lung cancer	0.000122	0.000525	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTA1—lung cancer	0.000121	0.000522	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	0.00012	0.000517	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ABCC3—lung cancer	0.00012	0.000516	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—EP300—lung cancer	0.000119	0.000513	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—AVP—lung cancer	0.000118	0.000508	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AKR1C1—lung cancer	0.000116	0.0005	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—NRAS—lung cancer	0.000115	0.000498	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GNG11—lung cancer	0.000115	0.000495	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000113	0.000486	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—UGT1A1—lung cancer	0.000112	0.000485	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—OXTR—lung cancer	0.000111	0.000481	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GRP—lung cancer	0.000111	0.000481	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—MAPK3—lung cancer	0.000111	0.000477	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	0.00011	0.000475	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GNG11—lung cancer	0.000108	0.000468	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—APOA1—lung cancer	0.000108	0.000465	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	0.000107	0.00046	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—lung cancer	0.000105	0.000454	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GNG11—lung cancer	0.000104	0.00045	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALDOA—lung cancer	0.000103	0.000445	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ADCY1—lung cancer	0.000103	0.000445	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	0.000103	0.000443	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NCOA3—lung cancer	0.0001	0.000432	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CXCL8—lung cancer	9.99e-05	0.000431	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—KRAS—lung cancer	9.93e-05	0.000429	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	9.85e-05	0.000425	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—HRAS—lung cancer	9.82e-05	0.000424	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ABCG2—lung cancer	9.75e-05	0.000421	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ADCY1—lung cancer	9.75e-05	0.000421	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—MMP1—lung cancer	9.74e-05	0.00042	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—COL4A2—lung cancer	9.64e-05	0.000416	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PTHLH—lung cancer	9.59e-05	0.000414	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HPGDS—lung cancer	9.56e-05	0.000413	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ENO2—lung cancer	9.56e-05	0.000413	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPP2R1B—lung cancer	9.5e-05	0.00041	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GIPR—lung cancer	9.39e-05	0.000405	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ADCY1—lung cancer	9.37e-05	0.000405	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—POMC—lung cancer	9.37e-05	0.000405	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTT1—lung cancer	9.27e-05	0.0004	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GCLC—lung cancer	9.16e-05	0.000396	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP2A6—lung cancer	9.16e-05	0.000396	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PPP2R1B—lung cancer	9.13e-05	0.000394	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.13e-05	0.000394	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—lung cancer	9.13e-05	0.000394	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ANXA1—lung cancer	9.02e-05	0.000389	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	9e-05	0.000388	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SDC4—lung cancer	8.77e-05	0.000379	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PTHLH—lung cancer	8.71e-05	0.000376	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ENO1—lung cancer	8.69e-05	0.000375	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	8.66e-05	0.000374	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—DUSP3—lung cancer	8.59e-05	0.000371	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—APP—lung cancer	8.55e-05	0.000369	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—ALB—lung cancer	8.54e-05	0.000369	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RHEB—lung cancer	8.43e-05	0.000364	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ANXA1—lung cancer	8.19e-05	0.000354	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—POMC—lung cancer	8.1e-05	0.00035	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GRM8—lung cancer	7.99e-05	0.000345	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	7.94e-05	0.000343	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—POMC—lung cancer	7.82e-05	0.000338	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP2E1—lung cancer	7.79e-05	0.000336	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL6—lung cancer	7.79e-05	0.000336	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—APP—lung cancer	7.77e-05	0.000335	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SKI—lung cancer	7.74e-05	0.000334	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NQO1—lung cancer	7.7e-05	0.000333	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.54e-05	0.000326	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—MMP2—lung cancer	7.54e-05	0.000325	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—HRAS—lung cancer	7.52e-05	0.000325	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.48e-05	0.000323	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—STK11—lung cancer	6.94e-05	0.0003	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PXN—lung cancer	6.72e-05	0.00029	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AVP—lung cancer	6.65e-05	0.000287	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKR1C1—lung cancer	6.58e-05	0.000284	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GRP—lung cancer	6.58e-05	0.000284	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—OXTR—lung cancer	6.58e-05	0.000284	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.52e-05	0.000281	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTP1—lung cancer	6.43e-05	0.000277	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CXCL8—lung cancer	6.26e-05	0.00027	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CAT—lung cancer	6.25e-05	0.00027	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.22e-05	0.000268	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GNG11—lung cancer	6.16e-05	0.000266	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ABCB1—lung cancer	6.08e-05	0.000263	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CXCL8—lung cancer	6.05e-05	0.000261	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AVP—lung cancer	6.04e-05	0.000261	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—TYMS—lung cancer	5.97e-05	0.000258	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTM1—lung cancer	5.91e-05	0.000255	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—VEGFC—lung cancer	5.86e-05	0.000253	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP1A1—lung cancer	5.6e-05	0.000242	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ERCC2—lung cancer	5.55e-05	0.00024	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADCY1—lung cancer	5.54e-05	0.000239	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PPP2R1B—lung cancer	5.4e-05	0.000233	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SMARCA4—lung cancer	5.4e-05	0.000233	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HSPB1—lung cancer	5.21e-05	0.000225	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTHLH—lung cancer	5.15e-05	0.000222	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ANXA1—lung cancer	4.84e-05	0.000209	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOA1—lung cancer	4.8e-05	0.000207	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FLT1—lung cancer	4.69e-05	0.000202	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CG—lung cancer	4.64e-05	0.0002	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.6e-05	0.000199	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOTCH3—lung cancer	4.59e-05	0.000198	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APP—lung cancer	4.59e-05	0.000198	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGF9—lung cancer	4.55e-05	0.000196	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—POMC—lung cancer	4.42e-05	0.000191	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CG—lung cancer	4.38e-05	0.000189	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—JUNB—lung cancer	4.34e-05	0.000188	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CG—lung cancer	4.22e-05	0.000182	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—POMC—lung cancer	4.17e-05	0.00018	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CD—lung cancer	4.08e-05	0.000176	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CREBBP—lung cancer	4.07e-05	0.000175	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—POMC—lung cancer	4.01e-05	0.000173	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—STK11—lung cancer	3.94e-05	0.00017	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL6R—lung cancer	3.92e-05	0.000169	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CD—lung cancer	3.85e-05	0.000166	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FOXO3—lung cancer	3.81e-05	0.000164	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALB—lung cancer	3.81e-05	0.000164	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MAP2K1—lung cancer	3.73e-05	0.000161	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CD—lung cancer	3.71e-05	0.00016	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AVP—lung cancer	3.57e-05	0.000154	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CB—lung cancer	3.56e-05	0.000154	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IGF1R—lung cancer	3.43e-05	0.000148	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCL8—lung cancer	3.42e-05	0.000148	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HES1—lung cancer	3.37e-05	0.000146	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CB—lung cancer	3.36e-05	0.000145	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PTGS2—lung cancer	3.33e-05	0.000144	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—RAF1—lung cancer	3.31e-05	0.000143	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—IL2—lung cancer	3.27e-05	0.000141	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CB—lung cancer	3.23e-05	0.000139	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCL8—lung cancer	3.1e-05	0.000134	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ERBB3—lung cancer	3.08e-05	0.000133	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL2—lung cancer	2.97e-05	0.000128	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TERT—lung cancer	2.96e-05	0.000128	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PTEN—lung cancer	2.9e-05	0.000125	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGFR1—lung cancer	2.87e-05	0.000124	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HIF1A—lung cancer	2.83e-05	0.000122	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—EP300—lung cancer	2.77e-05	0.00012	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOA1—lung cancer	2.73e-05	0.000118	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KDR—lung cancer	2.7e-05	0.000117	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CG—lung cancer	2.49e-05	0.000108	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KIT—lung cancer	2.49e-05	0.000108	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APC—lung cancer	2.49e-05	0.000108	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—NRAS—lung cancer	2.49e-05	0.000108	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EGF—lung cancer	2.46e-05	0.000106	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MAPK3—lung cancer	2.39e-05	0.000103	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—POMC—lung cancer	2.37e-05	0.000102	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—BRAF—lung cancer	2.34e-05	0.000101	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL6R—lung cancer	2.31e-05	9.98e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CREBBP—lung cancer	2.31e-05	9.97e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—EGFR—lung cancer	2.27e-05	9.79e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAP2K1—lung cancer	2.2e-05	9.51e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CD—lung cancer	2.19e-05	9.45e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CA—lung cancer	2.17e-05	9.36e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—KRAS—lung cancer	2.14e-05	9.25e-05	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CA—lung cancer	2.05e-05	8.84e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CA—lung cancer	1.97e-05	8.5e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MDM2—lung cancer	1.96e-05	8.47e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RAF1—lung cancer	1.95e-05	8.44e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ERBB2—lung cancer	1.93e-05	8.35e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CB—lung cancer	1.91e-05	8.24e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MTOR—lung cancer	1.91e-05	8.24e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCL8—lung cancer	1.83e-05	7.92e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HRAS—lung cancer	1.82e-05	7.86e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AKT1—lung cancer	1.77e-05	7.65e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CASP3—lung cancer	1.76e-05	7.58e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL2—lung cancer	1.75e-05	7.57e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL6—lung cancer	1.74e-05	7.53e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCND1—lung cancer	1.71e-05	7.37e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—JUN—lung cancer	1.71e-05	7.36e-05	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AKT1—lung cancer	1.67e-05	7.22e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MMP9—lung cancer	1.66e-05	7.16e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CDKN1A—lung cancer	1.65e-05	7.13e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTEN—lung cancer	1.65e-05	7.12e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AKT1—lung cancer	1.61e-05	6.94e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EP300—lung cancer	1.57e-05	6.79e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SRC—lung cancer	1.53e-05	6.6e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—VEGFA—lung cancer	1.49e-05	6.43e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—STAT3—lung cancer	1.47e-05	6.37e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NRAS—lung cancer	1.47e-05	6.35e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAPK3—lung cancer	1.41e-05	6.08e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MYC—lung cancer	1.37e-05	5.92e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EGFR—lung cancer	1.34e-05	5.79e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KRAS—lung cancer	1.27e-05	5.47e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CA—lung cancer	1.16e-05	5.02e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TP53—lung cancer	1.13e-05	4.86e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HRAS—lung cancer	1.08e-05	4.65e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL6—lung cancer	1.03e-05	4.45e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKT1—lung cancer	9.5e-06	4.1e-05	CbGpPWpGaD
